{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:26:05Z","timestamp":1793125565474,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R03DA051778"],"award-info":[{"award-number":["R03DA051778"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1K24DA056837"],"award-info":[{"award-number":["1K24DA056837"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11606-024-08799-3","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T10:04:11Z","timestamp":1717409051000},"page":"2097-2105","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association of Opioid Use Disorder Diagnosis with Management of Acute Low Back Pain: A Medicare Retrospective Cohort Analysis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1323-4554","authenticated-orcid":false,"given":"Patience","family":"Moyo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica S.","family":"Merlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Gairola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa I.","family":"Shireman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal N.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon D. L.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"issue":"6","key":"8799_CR1","doi-asserted-by":"publisher","first-page":"e316","DOI":"10.1016\/S2665-9913(23)00098-X","volume":"5","author":"Collaborators GBDLBP","year":"2023","unstructured":"Collaborators GBDLBP. Global, Regional, and National Burden of low back pain, 1990-2020, its attributable risk factors, and projections to 2050: a systematic analysis of the global burden of disease study 2021. Lancet Rheumatol. 2023;5(6):e316-e329. https:\/\/doi.org\/10.1016\/S2665-9913(23)00098-X.","journal-title":"Lancet Rheumatol."},{"issue":"7410","key":"8799_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/bmj.327.7410.323","volume":"327","author":"LH Pengel","year":"2003","unstructured":"Pengel LH, Herbert RD, Maher CG, Refshauge KM. Acute low back pain: systematic review of its prognosis. BMJ. 2003;327(7410):323. https:\/\/doi.org\/10.1136\/bmj.327.7410.323","journal-title":"BMJ."},{"issue":"1","key":"8799_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.spinee.2007.10.005","volume":"8","author":"S Dagenais","year":"2008","unstructured":"Dagenais S, Caro J, Haldeman S. A systematic review of low back pain cost of illness studies in the United States and internationally. Spine J. 2008;8(1):8-20. https:\/\/doi.org\/10.1016\/j.spinee.2007.10.005","journal-title":"Spine J."},{"issue":"24","key":"8799_CR4","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1001\/jama.2016.16885","volume":"316","author":"JL Dieleman","year":"2016","unstructured":"Dieleman JL, Baral R, Birger M, et al. US spending on personal health care and public health, 1996-2013. JAMA. 2016;316(24):2627-2646. https:\/\/doi.org\/10.1001\/jama.2016.16885","journal-title":"JAMA."},{"issue":"2","key":"8799_CR5","doi-asserted-by":"publisher","first-page":"e2037371","DOI":"10.1001\/jamanetworkopen.2020.37371","volume":"4","author":"JM Stevans","year":"2021","unstructured":"Stevans JM, Delitto A, Khoja SS, et al. Risk factors associated with transition from acute to chronic low back pain in US patients seeking primary care. JAMA Netw Open. 2021;4(2):e2037371. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.37371.","journal-title":"JAMA Netw Open."},{"issue":"2","key":"8799_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/pop.2013.0041","volume":"17","author":"M Cheatle","year":"2014","unstructured":"Cheatle M, Comer D, Wunsch M, Skoufalos A, Reddy Y. Treating pain in addicted patients: recommendations from an expert panel. Popul Health Manag. 2014;17(2):79-89. https:\/\/doi.org\/10.1089\/pop.2013.0041.","journal-title":"Popul Health Manag."},{"issue":"12","key":"8799_CR7","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1016\/j.jpain.2023.07.011","volume":"24","author":"CC Lin","year":"2023","unstructured":"Lin CC, Callaghan BC, Burke JF, et al. Prescription opioid initiation for neuropathy, headache, and low back pain: a US population-based Medicare study. J Pain. 2023;24(12):2268-2282. https:\/\/doi.org\/10.1016\/j.jpain.2023.07.011.","journal-title":"J Pain."},{"issue":"6","key":"8799_CR8","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.1111\/1475-6773.12984","volume":"53","author":"BK Frogner","year":"2018","unstructured":"Frogner BK, Harwood K, Andrilla CHA, Schwartz M, Pines JM. Physical therapy as the first point of care to treat low back pain: an instrumental variables approach to estimate impact on opioid prescription, health care utilization, and costs. Health Serv Res. 2018;53(6):4629-4646. https:\/\/doi.org\/10.1111\/1475-6773.12984.","journal-title":"Health Serv Res."},{"issue":"6","key":"8799_CR9","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3122\/jabfm.2017.06.170064","volume":"30","author":"A Thackeray","year":"2017","unstructured":"Thackeray A, Hess R, Dorius J, Brodke D, Fritz J. Relationship of opioid prescriptions to physical therapy referral and participation for Medicaid patients with new-onset low back pain. J Am Board Fam Med. 2017;30(6):784-794. https:\/\/doi.org\/10.3122\/jabfm.2017.06.170064.","journal-title":"J Am Board Fam Med."},{"issue":"9","key":"8799_CR10","doi-asserted-by":"publisher","first-page":"e028633","DOI":"10.1136\/bmjopen-2018-028633","volume":"9","author":"LE Kazis","year":"2019","unstructured":"Kazis LE, Ameli O, Rothendler J, et al. Observational retrospective study of the association of initial healthcare provider for new-onset low back pain with early and long-term opioid use. BMJ Open. 2019;9(9):e028633. https:\/\/doi.org\/10.1136\/bmjopen-2018-028633.","journal-title":"BMJ Open."},{"issue":"15","key":"8799_CR11","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016;315(15):1624-1645. https:\/\/doi.org\/10.1001\/jama.2016.1464.","journal-title":"JAMA."},{"issue":"3","key":"8799_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","volume":"71","author":"D Dowell","year":"2022","unstructured":"Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain - United States, 2022. MMWR Recomm Rep. 2022;71(3):1-95. https:\/\/doi.org\/10.15585\/mmwr.rr7103a1.","journal-title":"MMWR Recomm Rep."},{"issue":"11","key":"8799_CR13","doi-asserted-by":"publisher","first-page":"CPG1","DOI":"10.2519\/jospt.2021.0304","volume":"51","author":"SZ George","year":"2021","unstructured":"George SZ, Fritz JM, Silfies SP, et al. Interventions for the Management of Acute and Chronic Low Back Pain: Revision 2021. J Orthop Sports Phys Ther. 2021;51(11):CPG1-CPG60. https:\/\/doi.org\/10.2519\/jospt.2021.0304.","journal-title":"J Orthop Sports Phys Ther."},{"issue":"3","key":"8799_CR14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.7326\/M22-2917","volume":"176","author":"F Sandbrink","year":"2023","unstructured":"Sandbrink F, Murphy JL, Johansson M, et al. The use of opioids in the management of chronic pain: Synopsis of the 2022 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Ann Intern Med. 2023;176(3):388-397. https:\/\/doi.org\/10.7326\/M22-2917.","journal-title":"Ann Intern Med."},{"issue":"7","key":"8799_CR15","doi-asserted-by":"publisher","first-page":"514","DOI":"10.7326\/M16-2367","volume":"166","author":"A Qaseem","year":"2017","unstructured":"Qaseem A, Wilt TJ, McLean RM, et al. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166(7):514-530. https:\/\/doi.org\/10.7326\/M16-2367.","journal-title":"Ann Intern Med."},{"issue":"5","key":"8799_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMp1704633","volume":"377","author":"CW Goodman","year":"2017","unstructured":"Goodman CW, Brett AS. Gabapentin and pregabalin for pain - is increased prescribing a cause for concern? N Engl J Med. 2017;377(5):411-414. https:\/\/doi.org\/10.1056\/NEJMp1704633.","journal-title":"N Engl J Med."},{"key":"8799_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.0086","author":"CW Goodman","year":"2019","unstructured":"Goodman CW, Brett AS. A clinical overview of off-label use of gabapentinoid drugs. JAMA Intern Med. 2019. https:\/\/doi.org\/10.1001\/jamainternmed.2019.0086.","journal-title":"JAMA Intern Med."},{"issue":"11","key":"8799_CR18","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1176\/appi.ps.202000338","volume":"72","author":"B Costales","year":"2021","unstructured":"Costales B, Goodin AJ. Outpatient off-label gabapentin use for psychiatric indications among U.S. adults, 2011-2016. Psychiatr Serv. 2021;72(11):1246-1253. https:\/\/doi.org\/10.1176\/appi.ps.202000338.","journal-title":"Psychiatr Serv."},{"issue":"7","key":"8799_CR19","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jpain.2022.01.006","volume":"23","author":"LR Gorfinkel","year":"2022","unstructured":"Gorfinkel LR, Hasin D, Saxon AJ, et al. Trends in prescriptions for non-opioid pain medications among U.S. adults with moderate or severe pain, 2014-2018. J Pain. 2022;23(7):1187-1195. https:\/\/doi.org\/10.1016\/j.jpain.2022.01.006.","journal-title":"J Pain."},{"issue":"7","key":"8799_CR20","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/add.13324","volume":"111","author":"RV Smith","year":"2016","unstructured":"Smith RV, Havens JR, Walsh SL. Gabapentin misuse, abuse and diversion: a systematic review. Addiction. 2016;111(7):1160-1174. https:\/\/doi.org\/10.1111\/add.13324.","journal-title":"Addiction."},{"issue":"8","key":"8799_CR21","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.sapharm.2018.06.018","volume":"15","author":"KE Evoy","year":"2019","unstructured":"Evoy KE, Covvey JR, Peckham AM, Ochs L, Hultgren KE. Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: an analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS). Res Social Adm Pharm. 2019;15(8):953-958. https:\/\/doi.org\/10.1016\/j.sapharm.2018.06.018.","journal-title":"Res Social Adm Pharm."},{"issue":"601","key":"8799_CR22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3399\/bjgp12X653516","volume":"62","author":"BH Smith","year":"2012","unstructured":"Smith BH, Higgins C, Baldacchino A, Kidd B, Bannister J. Substance misuse of gabapentin. Br J Gen Pract. 2012;62(601):406-407. https:\/\/doi.org\/10.3399\/bjgp12X653516.","journal-title":"Br J Gen Pract."},{"key":"8799_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/add.15189","author":"L Zhou","year":"2020","unstructured":"Zhou L, Bhattacharjee S, Kwoh CK, et al. Dual-Trajectories of opioid and gabapentinoid use and risk of subsequent drug overdose among Medicare beneficiaries in the United States: a retrospective cohort study. Addiction. 2020. https:\/\/doi.org\/10.1111\/add.15189.","journal-title":"Addiction."},{"issue":"10","key":"8799_CR24","doi-asserted-by":"publisher","first-page":"e1002396","DOI":"10.1371\/journal.pmed.1002396","volume":"14","author":"T Gomes","year":"2017","unstructured":"Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study. PLoS Med. 2017;14(10):e1002396. https:\/\/doi.org\/10.1371\/journal.pmed.1002396.","journal-title":"PLoS Med."},{"issue":"4","key":"8799_CR25","first-page":"51","volume":"105","author":"P Moyo","year":"2022","unstructured":"Moyo P, Schmidt C, Lee Y, et al. Receipt of physical therapy and chiropractic care by adults diagnosed with chronic pain: analysis of the 2016-2018 Rhode Island All Payer Claims Database. R I Med J (2013). 2022;105(4):51-56.","journal-title":"R I Med J (2013)"},{"issue":"10","key":"8799_CR26","doi-asserted-by":"publisher","first-page":"igad085","DOI":"10.1093\/geroni\/igad085","volume":"7","author":"E Choudry","year":"2023","unstructured":"Choudry E, Rofe KL, Konnyu K, et al. Treatment patterns and population characteristics of nonpharmacological management of chronic pain in the United States\u2019 Medicare population: a scoping review. Innov Aging. 2023;7(10):igad085. https:\/\/doi.org\/10.1093\/geroni\/igad085.","journal-title":"Innov Aging."},{"issue":"9","key":"8799_CR27","doi-asserted-by":"publisher","first-page":"e2333251","DOI":"10.1001\/jamanetworkopen.2023.33251","volume":"6","author":"F Bhondoekhan","year":"2023","unstructured":"Bhondoekhan F, Marshall BDL, Shireman TI, Trivedi AN, Merlin JS, Moyo P. Racial and ethnic differences in receipt of nonpharmacologic care for chronic low back pain among Medicare beneficiaries with OUD. JAMA Netw Open. 2023;6(9):e2333251. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.33251.","journal-title":"JAMA Netw Open."},{"issue":"3","key":"8799_CR28","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jpain.2023.10.003","volume":"25","author":"P Moyo","year":"2024","unstructured":"Moyo P, Merlin JS, George M, Shireman TI, Marshall BDL. Association of opioid use disorder diagnosis with use of physical therapy and chiropractic care among chronic low back pain patients: a group-based trajectory analysis. J Pain. 2024;25(3):742-754. https:\/\/doi.org\/10.1016\/j.jpain.2023.10.003.","journal-title":"J Pain."},{"key":"8799_CR29","doi-asserted-by":"publisher","first-page":"109930","DOI":"10.1016\/j.drugalcdep.2023.109930","volume":"248","author":"P Moyo","year":"2023","unstructured":"Moyo P, Vaillant J, Girard A, et al. Prevalence of opioid and nonopioid pain management therapies among Medicare beneficiaries with musculoskeletal pain conditions from 2016 to 2019. Drug Alcohol Depend. 2023;248:109930. https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.109930.","journal-title":"Drug Alcohol Depend."},{"issue":"11","key":"8799_CR30","doi-asserted-by":"publisher","first-page":"e2240612","DOI":"10.1001\/jamanetworkopen.2022.40612","volume":"5","author":"KT Pritchard","year":"2022","unstructured":"Pritchard KT, Baillargeon J, Lee WC, Raji MA, Kuo YF. Trends in the use of opioids vs nonpharmacologic treatments in adults with pain, 2011-2019. JAMA Netw Open. 2022;5(11):e2240612. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.40612.","journal-title":"JAMA Netw Open."},{"issue":"6","key":"8799_CR31","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/ADM.0000000000000255","volume":"10","author":"JR Gaither","year":"2016","unstructured":"Gaither JR, Goulet JL, Becker WC, et al. The effect of substance use disorders on the association between guideline-concordant long-term opioid therapy and all-cause mortality. J Addict Med. 2016;10(6):418-428. https:\/\/doi.org\/10.1097\/ADM.0000000000000255.","journal-title":"J Addict Med."},{"key":"8799_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jsat.2019.07.015","volume":"105","author":"LA Uebelacker","year":"2019","unstructured":"Uebelacker LA, Van Noppen D, Tremont G, Bailey G, Abrantes A, Stein M. A pilot study assessing acceptability and feasibility of Hatha yoga for chronic pain in people receiving opioid agonist therapy for opioid use disorder. J Subst Abuse Treat. 2019;105:19-27. https:\/\/doi.org\/10.1016\/j.jsat.2019.07.015.","journal-title":"J Subst Abuse Treat."},{"issue":"4","key":"8799_CR33","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","volume":"156","author":"KE Vowles","year":"2015","unstructured":"Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156(4):569-576. https:\/\/doi.org\/10.1097\/01.j.pain.0000460357.01998.f1.","journal-title":"Pain."},{"issue":"5","key":"8799_CR34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/09540261.2018.1514369","volume":"30","author":"TJ Speed","year":"2018","unstructured":"Speed TJ, Parekh V, Coe W, Antoine D. Comorbid chronic pain and opioid use disorder: literature review and potential treatment innovations. Int Rev Psychiatry. 2018;30(5):136-146. https:\/\/doi.org\/10.1080\/09540261.2018.1514369.","journal-title":"Int Rev Psychiatry."},{"key":"8799_CR35","doi-asserted-by":"publisher","first-page":"k3949","DOI":"10.1136\/bmj.k3949","volume":"362","author":"L Gorfinkel","year":"2018","unstructured":"Gorfinkel L, Voon P, Wood E, Klimas J. Diagnosing opioid addiction in people with chronic pain. BMJ. 2018;362:k3949. https:\/\/doi.org\/10.1136\/bmj.k3949.","journal-title":"BMJ."},{"issue":"3","key":"8799_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1353\/nib.2018.0072","volume":"8","author":"M Szalavitz","year":"2018","unstructured":"Szalavitz M. No one should have to prove their worth to get medical care, regardless of addiction or pain. Narrat Inq Bioeth. 2018;8(3):233-237. https:\/\/doi.org\/10.1353\/nib.2018.0072.","journal-title":"Narrat Inq Bioeth."},{"issue":"2","key":"8799_CR37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.psc.2012.03.006","volume":"35","author":"K Miotto","year":"2012","unstructured":"Miotto K, Kaufman A, Kong A, Jun G, Schwartz J. Managing co-occurring substance use and pain disorders. Psychiatr Clin North Am. 2012;35(2):393-409. https:\/\/doi.org\/10.1016\/j.psc.2012.03.006.","journal-title":"Psychiatr Clin North Am."},{"issue":"1","key":"8799_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13011-017-0120-7","volume":"12","author":"P Voon","year":"2017","unstructured":"Voon P, Karamouzian M, Kerr T. Chronic pain and opioid misuse: a review of reviews. Subst Abuse Treat Prev Policy. 2017;12(1):36. https:\/\/doi.org\/10.1186\/s13011-017-0120-7.","journal-title":"Subst Abuse Treat Prev Policy."},{"issue":"3","key":"8799_CR39","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.pain.2010.10.009","volume":"152","author":"BJ Morasco","year":"2011","unstructured":"Morasco BJ, Gritzner S, Lewis L, Oldham R, Turk DC, Dobscha SK. Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder. Pain. 2011;152(3):488-497. https:\/\/doi.org\/10.1016\/j.pain.2010.10.009.","journal-title":"Pain."},{"issue":"6","key":"8799_CR40","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1016\/j.bja.2018.09.019","volume":"122","author":"C Higgins","year":"2019","unstructured":"Higgins C, Smith BH, Matthews K. Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis. Br J Anaesth. 2019;122(6):e114-e126. https:\/\/doi.org\/10.1016\/j.bja.2018.09.019.","journal-title":"Br J Anaesth."},{"key":"8799_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1747-597X-8-35","volume":"8","author":"K Lang","year":"2013","unstructured":"Lang K, Neil J, Wright J, Dell CA, Berenbaum S, El-Aneed A. Qualitative investigation of barriers to accessing care by people who inject drugs in Saskatoon, Canada: Perspectives of Service Providers. Subst Abuse Treat Prev Policy. 2013;8:35. https:\/\/doi.org\/10.1186\/1747-597X-8-35.","journal-title":"Subst Abuse Treat Prev Policy."},{"issue":"1","key":"8799_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12875-017-0608-2","volume":"18","author":"WC Becker","year":"2017","unstructured":"Becker WC, Dorflinger L, Edmond SN, Islam L, Heapy AA, Fraenkel L. Barriers and facilitators to use of non-pharmacological treatments in chronic pain. BMC Fam Pract. 2017;18(1):41. https:\/\/doi.org\/10.1186\/s12875-017-0608-2.","journal-title":"BMC Fam Pract."},{"issue":"7","key":"8799_CR43","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/pm\/pnx220","volume":"19","author":"KF Giannitrapani","year":"2018","unstructured":"Giannitrapani KF, Ahluwalia SC, McCaa M, Pisciotta M, Dobscha S, Lorenz KA. Barriers to using nonpharmacologic approaches and reducing opioid use in primary care. Pain Med. 2018;19(7):1357-1364. https:\/\/doi.org\/10.1093\/pm\/pnx220.","journal-title":"Pain Med."},{"issue":"3","key":"8799_CR44","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/jnu.12837","volume":"55","author":"MK McCurry","year":"2023","unstructured":"McCurry MK, Avery-Desmarais S, Schuler M, Tyo M, Viveiros J, Kauranen B. Perceived stigma, barriers, and facilitators experienced by members of the opioid use disorder community when seeking healthcare. J Nurs Scholarsh. 2023;55(3):701-710. https:\/\/doi.org\/10.1111\/jnu.12837.","journal-title":"J Nurs Scholarsh."},{"issue":"5","key":"8799_CR45","doi-asserted-by":"publisher","first-page":"e204514","DOI":"10.1001\/jamanetworkopen.2020.4514","volume":"3","author":"CA Mikosz","year":"2020","unstructured":"Mikosz CA, Zhang K, Haegerich T, et al. Indication-specific opioid prescribing for US patients with Medicaid or Private Insurance, 2017. JAMA Netw Open. 2020;3(5):e204514. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.4514.","journal-title":"JAMA Netw Open."},{"issue":"5","key":"8799_CR46","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jpain.2017.02.421","volume":"18","author":"ML Kent","year":"2017","unstructured":"Kent ML, Tighe PJ, Belfer I, et al. The ACTTION-APS-AAPM Pain Taxonomy (AAAPT) multidimensional approach to classifying acute pain conditions. J Pain. 2017;18(5):479-489. https:\/\/doi.org\/10.1016\/j.jpain.2017.02.421.","journal-title":"J Pain."},{"issue":"4","key":"8799_CR47","doi-asserted-by":"publisher","first-page":"e229191","DOI":"10.1001\/jamanetworkopen.2022.9191","volume":"5","author":"BL DiPrete","year":"2022","unstructured":"DiPrete BL, Ranapurwala SI, Maierhofer CN, et al. Association of opioid dose reduction with opioid overdose and opioid use disorder among patients receiving high-dose, long-term opioid therapy in North Carolina. JAMA Netw Open. 2022;5(4):e229191. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.9191.","journal-title":"JAMA Netw Open."},{"key":"8799_CR48","doi-asserted-by":"publisher","unstructured":"Glanz JM, Xu S, Narwaney KJ, et al. Association between opioid dose reduction rates and overdose among patients prescribed long-term opioid therapy. Subst Abus. 2023:8897077231186216. https:\/\/doi.org\/10.1177\/08897077231186216.","DOI":"10.1177\/08897077231186216"},{"issue":"6","key":"8799_CR49","doi-asserted-by":"publisher","first-page":"367","DOI":"10.7326\/M18-1243","volume":"169","author":"ASB Bohnert","year":"2018","unstructured":"Bohnert ASB, Guy GP, Jr., Losby JL. Opioid prescribing in the United States before and after the centers for disease control and prevention\u2019s 2016 opioid guideline. Ann Intern Med. 2018;169(6):367-375. https:\/\/doi.org\/10.7326\/M18-1243.","journal-title":"Ann Intern Med."},{"issue":"8","key":"8799_CR50","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/AJP.0000000000000948","volume":"37","author":"N Dasgupta","year":"2021","unstructured":"Dasgupta N, Wang Y, Bae J, et al. Inches, centimeters, and yards: overlooked definition choices inhibit interpretation of morphine equivalence. Clin J Pain. 2021;37(8):565-574. https:\/\/doi.org\/10.1097\/AJP.0000000000000948.","journal-title":"Clin J Pain."},{"issue":"10","key":"8799_CR51","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.jpain.2012.07.007","volume":"13","author":"DC McDonald","year":"2012","unstructured":"McDonald DC, Carlson K, Izrael D. Geographic variation in opioid prescribing in the U.S. J Pain. 2012;13(10):988-996. https:\/\/doi.org\/10.1016\/j.jpain.2012.07.007.","journal-title":"J Pain."},{"issue":"9","key":"8799_CR52","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1097\/MLR.0000000000000183","volume":"52","author":"NE Morden","year":"2014","unstructured":"Morden NE, Munson JC, Colla CH, et al. Prescription opioid use among disabled Medicare beneficiaries: intensity, trends, and Regional variation. Med Care. 2014;52(9):852-859. https:\/\/doi.org\/10.1097\/MLR.0000000000000183.","journal-title":"Med Care."},{"issue":"6","key":"8799_CR53","first-page":"20","volume":"18","author":"JM Whedon","year":"2012","unstructured":"Whedon JM, Song Y. Racial disparities in the use of chiropractic care under Medicare. Altern Ther Health Med. 2012;18(6):20-26.","journal-title":"Altern Ther Health Med."},{"issue":"2","key":"8799_CR54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jmpt.2011.12.004","volume":"35","author":"JM Whedon","year":"2012","unstructured":"Whedon JM, Song Y. Geographic variations in availability and use of chiropractic under Medicare. J Manipulative Physiol Ther. 2012;35(2):101-109. https:\/\/doi.org\/10.1016\/j.jmpt.2011.12.004.","journal-title":"J Manipulative Physiol Ther."},{"key":"8799_CR55","doi-asserted-by":"publisher","unstructured":"Huang AW, Meyers DJ. Assessing the validity of race and ethnicity coding in administrative Medicare data for reporting outcomes among Medicare advantage beneficiaries from 2015 to 2017. Health Serv Res. 2023;58(5):1045-1055. https:\/\/doi.org\/10.1111\/1475-6773.14197.","DOI":"10.1111\/1475-6773.14197"},{"issue":"7","key":"8799_CR56","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jclinepi.2010.10.004","volume":"64","author":"JJ Gagne","year":"2011","unstructured":"Gagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011;64(7):749-759. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.10.004.","journal-title":"J Clin Epidemiol."},{"issue":"4","key":"8799_CR57","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s11606-009-0908-x","volume":"24","author":"KM Berg","year":"2009","unstructured":"Berg KM, Arnsten JH, Sacajiu G, Karasz A. Providers\u2019 experiences treating chronic pain among opioid-dependent drug users. J Gen Intern Med. 2009;24(4):482-488. https:\/\/doi.org\/10.1007\/s11606-009-0908-x.","journal-title":"J Gen Intern Med."},{"issue":"2","key":"8799_CR58","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","volume":"38","author":"E Proctor","year":"2011","unstructured":"Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65-76. https:\/\/doi.org\/10.1007\/s10488-010-0319-7.","journal-title":"Adm Policy Ment Health."},{"issue":"1","key":"8799_CR59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated consolidated framework for implementation research based on user feedback. Implement Sci. 2022;17(1):75. https:\/\/doi.org\/10.1186\/s13012-022-01245-0.","journal-title":"Implement Sci."},{"issue":"1","key":"8799_CR60","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.pmn.2019.08.003","volume":"21","author":"B St Marie","year":"2020","unstructured":"St Marie B, Broglio K. Managing pain in the setting of opioid use disorder. Pain Manag Nurs. 2020;21(1):26-34. https:\/\/doi.org\/10.1016\/j.pmn.2019.08.003.","journal-title":"Pain Manag Nurs."},{"key":"8799_CR61","unstructured":"Veazie S, Mackey K, Bourne D, Peterson K. Evidence brief: managing acute pain in patients with opioid use disorder on medication-assisted treatment. 2019. VA ESP Project #09\u2013199. Accessed 2 October 2023."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-08799-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-024-08799-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-08799-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:05:59Z","timestamp":1764266759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-024-08799-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":61,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["8799"],"URL":"https:\/\/doi.org\/10.1007\/s11606-024-08799-3","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,3]]},"assertion":[{"value":"22 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"Dr. Moyo reported receiving grants from the National Institutes of Health during the conduct of the study, serving as a technical expert panelist for an Abt Associates study focused on opioid use and misuse in older adults, and being a member of a National Academies of Sciences, Engineering, and Medicine ad hoc committee on evaluating the effects of opioids and benzodiazepines on all-cause mortality in Veterans. Dr. Merlin has received research funding from the Cambia Health Foundation. Dr. Marshall has received research funding from Arnold Ventures, the Cigna Foundation, and Open Society Foundations during the conduct of the study. No other disclosures were reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}